Loading...
XJPX
2927
Market cap83mUSD
Jun 13, Last price  
857.00JPY
1D
-0.58%
1Q
2.39%
Jan 2017
4.90%
IPO
-38.79%
Name

AFC-HD AMS Life Science Co Ltd

Chart & Performance

D1W1MN
P/E
9.62
P/S
0.40
EPS
89.05
Div Yield, %
3.50%
Shrs. gr., 5y
Rev. gr., 5y
13.18%
Revenues
30.19b
+18.01%
10,221,995,00012,813,393,00014,448,963,00014,653,831,00014,794,674,00014,366,178,00013,727,896,00014,415,229,00014,631,256,00015,141,754,00015,795,643,00016,252,889,00015,819,281,00022,368,076,00022,997,127,00025,579,009,00030,185,451,000
Net income
1.25b
+13.56%
354,824,000129,717,000195,042,000490,159,000569,044,000572,392,000282,979,000605,503,000489,600,000465,893,000736,680,000783,292,000676,683,0001,495,554,000735,353,0001,102,564,0001,252,067,000
CFO
1.54b
+77.99%
1,129,622,000683,872,0001,121,107,000512,319,0001,375,537,0001,576,058,000892,821,000856,809,000854,432,000525,584,0001,221,626,0001,131,930,0001,299,011,0002,582,697,0001,492,417,000865,280,0001,540,093,000
Dividend
Aug 28, 20250 JPY/sh

Profile

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and supplements. It plans, researches, develops, and processes, as well as completes dietary supplement and cosmetics. The company offers health foods in various forms, such as tablets, soft and hard capsules, granules, soft drinks, and jellies. Its cosmetic products include facial cleansing, lotions, milky lotions, makeup oils, cleansing creams, and liquid cosmetics.. The company also wholesales dietary supplements and cosmetics; collects health-related information; plans and produces TV commercials, TV shopping channels, and video packages; publishes health magazines; and operates day and night care center under the Hello House name, and prep school under the Hello Gakuen name. In addition, it sells dietary supplements and cosmetics through mail orders; operates Internet shops; offers Kanpou, a general practitioner medicine for medical care; and produces and sells health care merchandise. The company operates in Japan, rest of Asia, and internationally. The company was formerly known as AMS Life Science Co., Ltd. and changed its name to AFC-HD AMS Life Science Co., Ltd. in March 2010. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
IPO date
Mar 03, 2005
Employees
799
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑082016‑082015‑08
Income
Revenues
30,185,451
18.01%
25,579,009
11.23%
22,997,127
2.81%
Cost of revenue
19,693,596
23,927,189
21,832,988
Unusual Expense (Income)
NOPBT
10,491,855
1,651,820
1,164,139
NOPBT Margin
34.76%
6.46%
5.06%
Operating Taxes
665,397
439,356
497,922
Tax Rate
6.34%
26.60%
42.77%
NOPAT
9,826,458
1,212,464
666,217
Net income
1,252,067
13.56%
1,102,564
49.94%
735,353
-50.83%
Dividends
(418,804)
(385,107)
(421,999)
Dividend yield
3.44%
3.88%
Proceeds from repurchase of equity
(79,568)
(288,891)
BB yield
0.71%
2.66%
Debt
Debt current
9,598,513
8,218,895
6,998,833
Long-term debt
13,293,145
11,324,017
10,144,069
Deferred revenue
Other long-term liabilities
1,927,666
1,481,282
1,283,097
Net debt
10,718,579
7,820,755
5,916,112
Cash flow
Cash from operating activities
1,540,093
865,280
1,492,417
CAPEX
(3,406,797)
(1,939,681)
(957,971)
Cash from investing activities
(2,761,467)
(1,946,009)
(1,077,917)
Cash from financing activities
2,232,074
1,881,171
1,159,612
FCF
7,577,287
(1,907,926)
227,487
Balance
Cash
12,172,810
11,182,021
10,377,778
Long term investments
269
540,136
849,012
Excess cash
10,663,806
10,443,207
10,076,934
Stockholders' equity
11,571,097
10,769,753
10,110,306
Invested Capital
28,113,614
23,734,332
20,610,972
ROIC
37.90%
5.47%
3.35%
ROCE
26.90%
4.80%
3.76%
EV
Common stock shares outstanding
14,053
14,119
Price
833.00
4.65%
796.00
3.38%
770.00
-33.04%
Market cap
11,185,846
2.89%
10,871,990
-32.81%
EV
19,055,231
16,794,160
EBITDA
11,577,415
2,635,817
2,170,759
EV/EBITDA
7.23
7.74
Interest
101,271
57,555
57,591
Interest/NOPBT
0.97%
3.48%
4.95%